amynicole – The CDC projects that the COVID-19 variant NB.1.8.1 could now cause more than 33% of infections in the United States. This variant previously caused a surge in hospitalizations in parts of Asia. The agency’s recent data suggests NB.1.8.1 spreads rapidly across the country, raising concerns about its high transmissibility compared to earlier variants.
Airport Surveillance Reveals Rising NB.1.8.1 Cases in International Travelers
CDC’s airport monitoring program detected NB.1.8.1 in travelers from multiple countries last month. In the last week of May, nearly 50% of COVID cases detected in this program involved the NB.1.8.1 variant. Although the CDC warns that recent data has low precision and a wide margin of error, the trend highlights the variant’s growing presence in the U.S. population. This increase suggests that NB.1.8.1 is spreading quickly through community transmission. Health experts continue to closely monitor the situation to understand its impact on public health and prepare appropriate responses to limit further spread.
Experts Explain NB.1.8.1’s High Transmissibility and Symptoms
Experts say NB.1.8.1 does not cause more severe illness than previous variants but spreads more easily. Subhash Verma, a microbiology professor, explained the variant’s growth advantage and its similar symptoms to earlier COVID strains. Typical symptoms include cough, sore throat, fever, and fatigue, which remain consistent across infections. Health officials emphasize the importance of continued vigilance, including testing and vaccination, to manage the spread. Although the variant is more transmissible, current treatments and preventive measures remain effective. Researchers are also studying its impact on vulnerable populations to guide future public health recommendations.
Changes in COVID Vaccine Access and Recommendations in the U.S.
The Trump administration and health agencies recently changed COVID vaccine access policies. The FDA will continue approving updated vaccines for seniors and high-risk individuals but will require major clinical trials for broader approvals. This limits vaccine availability for healthy people without underlying conditions this fall. Additionally, these new rules aim to ensure vaccine safety and effectiveness by demanding more rigorous testing. Public health experts stress that vulnerable groups remain the priority for vaccination efforts. Meanwhile, vaccine manufacturers are preparing to meet the new requirements, which may delay widespread vaccine distribution. This shift reflects a more targeted approach to COVID-19 prevention moving forward.
CDC Updates Vaccination Guidelines for Children and Pregnant Women
Health officials modified vaccine recommendations for children and pregnant women. The CDC states that children 6 months and older may receive COVID vaccines based on a healthcare provider’s advice and parental preference. Pregnant women without health risks also have the option to get vaccinated, reflecting a more personalized approach to COVID prevention.
